Figure 5
From: A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma
Braf and p300 expression and 5-year patient survival. Kaplan-Meier survival analyses of correlation between Braf & p300 expression and 5-year overall (left panels) and disease-specific (right panels) survival of melanoma patients. (A and B) correlation between Braf and nuclear p300 expression, and patient survival. (C and D) correlation between Braf and cytoplasmic p300 expression, and patient survival. Blue line represents the cases with low Braf and low p300; pink line, cases with low Braf and high p300; yellow line, high Braf and low p300; sky blue line, high Braf and high p300.